Zhuqing Shi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Venues

The Prostate

Prostate cancer and prostatic diseases

Cancer medicine

Clinical genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Jianfeng Xu, Zhuqing Shi, Jun Wei, Rong Na, W Kyle Resurreccion, Chi-Hsiung Wang, Chris Sample, Misop Han, S Lilly Zheng, Kathleen A Cooney, Brian T Helfand, William B Isaacs
KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression. Prostate cancer and prostatic diseases 25 (4) (2022)
Jianfeng Xu, W Kyle Resurreccion, Zhuqing Shi, Jun Wei, Chi-Hsiung Wang, S Lilly Zheng, Peter J Hulick, Ashley E Ross, Christian P Pavlovich, Brian T Helfand, William B Isaacs
Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. Prostate cancer and prostatic diseases 25 (3) (2022)
Zhuqing Shi, Lucy Lu, William Kyle Resurreccion, Wancai Yang, Jun Wei, Qiang Wang, Valentina Engelmann, Siqun Lilly Zheng, Kathleen A Cooney, William B Isaacs, Brian T Helfand, Jim Lu, Jianfeng Xu
Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. The Prostate 82 (1) (2021)
Jun Wei, Wancai Yang, Zhuqing Shi, Lucy Lu, Qiang Wang, W Kyle Resurreccion, Valentina Engelmann, S Lilly Zheng, Peter J Hulick, Kathleen A Cooney, William B Isaacs, Brian T Helfand, Jim Lu, Jianfeng Xu
Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. The Prostate 81 (13) (2021)
Jianfeng Xu, William B Isaacs, Mufaddal Mamawala, Zhuqing Shi, Patricia Landis, Jacqueline Petkewicz, Jun Wei, Chi-Hsiung Wang, W Kyle Resurreccion, Rong Na, Yasin Bhanji, Kristian Novakovic, Patrick C Walsh, S Lilly Zheng, Brian T Helfand, Christian P Pavlovich
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients. The Prostate 81 (10) (2021)
Mary H Black, Shuwei Li, Holly LaDuca, Min-Tzu Lo, Jefferey Chen, Robert Hoiness, Stephanie Gutierrez, Brigette Tippin-Davis, Hsiao-Mei Lu, Marta Gielzak, Kathleen Wiley, Zhuqing Shi, Jun Wei, Siqun Lilly Zheng, Brian T Helfand, William B Isaacs, Jianfeng Xu
Validation of a prostate cancer polygenic risk score. The Prostate 80 (15) (2020)
Hongjie Yu, Zhuqing Shi, Yishuo Wu, Chi-Hsiung Wang, Xiaoling Lin, Chelsea Perschon, William B Isaacs, Brian T Helfand, S Lilly Zheng, David Duggan, Zengnan Mo, Daru Lu, Jianfeng Xu
Concept and benchmarks for assessing narrow-sense validity of genetic risk score values. The Prostate 79 (10) (2019)
Zhuqing Shi, Hongjie Yu, Yishuo Wu, Xiaoling Lin, Quanwa Bao, Haifei Jia, Chelsea Perschon, David Duggan, Brian T Helfand, Siqun L Zheng, Jianfeng Xu
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts. Cancer medicine 8 (6) (2019)
Hongjie Yu, Zhuqing Shi, Xiaoling Lin, Quanwa Bao, Haifei Jia, Jun Wei, Brian T Helfand, Siqun L Zheng, David Duggan, Daru Lu, Zengnan Mo, Jianfeng Xu
Broad- and narrow-sense validity performance of three polygenic risk score methods for prostate cancer risk assessment. The Prostate 80 (1) (2019)
Zhuqing Shi, Hongjie Yu, Yishuo Wu, Madison Ford, Chelsea Perschon, Chihsiung Wang, Siqun L Zheng, Jianfeng Xu
Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease. Clinical genetics 95 (2) (2018)

Zhuqing Shi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhuqing Shi